XML 25 R14.htm IDEA: XBRL DOCUMENT v3.5.0.2
Goodwill and Intangible Assets, Net
9 Months Ended
Sep. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets, Net
GOODWILL AND INTANGIBLE ASSETS, NET
Goodwill
Our $639.5 million goodwill balance consisted of $198.1 million of goodwill acquired through the November 2014 Lumara Health acquisition and $441.4 million acquired through the August 2015 CBR acquisition. During the nine months ended September 30, 2016, the CBR goodwill increased by $0.3 million related to measurement period net tax adjustments. These measurement period adjustments have been reflected as current period adjustments in accordance with ASU 2015-16, discussed below in Note S, “Recently Issued and Proposed Accounting Pronouncements.” As of September 30, 2016, we had no accumulated impairment losses related to goodwill. 
Intangible Assets
As of September 30, 2016 and December 31, 2015, our identifiable intangible assets consisted of the following (in thousands):
 
September 30, 2016
 
December 31, 2015
 
 
 
Accumulated
 
 
 
 
 
 
 
Accumulated
 
 
 
Cost
 
Amortization
 
Impairments
 
Net
 
Cost
 
Amortization
 
Net
Amortizable intangible assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
Makena base technology
$
797,100

 
$
105,207

 
$

 
$
691,893

 
$
797,100

 
$
56,540

 
$
740,560

CBR customer relationships
297,000

 
10,458

 

 
286,542

 
297,000

 
1,061

 
295,939

CBR Favorable lease
358

 
119

 
239

 

 
358

 
63

 
295

MuGard Rights
16,893

 
1,169

 
15,724

 

 
16,893

 
1,016

 
15,877

 
1,111,351

 
116,953

 
15,963

 
978,435

 
1,111,351

 
58,680

 
1,052,671

Indefinite-lived intangible assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
Makena IPR&D
79,100

 

 

 
79,100

 
79,100

 

 
79,100

CBR trade names and trademarks
65,000

 

 

 
65,000

 
65,000

 

 
65,000

Total intangible assets
$
1,255,451

 
$
116,953

 
$
15,963

 
$
1,122,535

 
$
1,255,451

 
$
58,680

 
$
1,196,771



As of September 30, 2016, the weighted average remaining amortization period for our finite-lived intangible assets was approximately nine years.
The Makena base technology and IPR&D intangible assets were acquired in November 2014 in connection with our acquisition of Lumara Health. Amortization of the Makena base technology asset is being recognized using an economic consumption model over 20 years, which we believe is an appropriate amortization period due to the estimated economic lives of the product rights and related intangibles.
The CBR intangible assets (the CBR customer relationships, favorable lease and trade names and trademarks) were acquired in August 2015 in connection with our acquisition of CBR. Amortization of the CBR customer relationships is being recognized using an estimated useful life of 20 years, which we believe is an appropriate amortization period due to the estimated economic lives of the CBR intangible assets. The favorable lease was being amortized on a straight-line basis over the remaining term of the lease. On May 4, 2016, we entered into a sublease arrangement for a portion of our CBR office space in San Bruno, California with a sublessee at a rate lower than the market rate used to determine the favorable lease intangible asset. We reevaluated the favorable lease asset based on the negotiated sublease rate, resulting in an impairment charge for the full $0.2 million net intangible asset in the second quarter of 2016.
The MuGard Rights were acquired from Abeona in June 2013. Amortization of the MuGard Rights was being recognized using an economic consumption model over ten years, which represented our best estimate of the period over which we expected the majority of the asset’s cash flows to be derived. Based on events in the second quarter of 2016, we determined that broader reimbursement coverage for MuGard by government payors was unlikely based on recent interactions with those agencies and assessed the MuGard Rights for potential impairment. From this assessment, we concluded that based on the lack of broad reimbursement and insurance coverage for MuGard and the resulting decrease in expected revenues and cash flows, the projected undiscounted cash flows were less than the book value, indicating impairment of this intangible asset. As a result of an analysis of the fair value of the net MuGard Rights intangible asset as compared to its recorded book value, we recognized an impairment charge for the full $15.7 million net intangible asset in the second quarter of 2016.
 
See Note C, “Business Combinations,” for additional information on our intangible assets.
Total amortization expense for the nine months ended September 30, 2016 and 2015, was $58.3 million and $13.9 million, respectively. Amortization expense for Makena base technology and the MuGard Rights is recorded in cost of product sales in our condensed consolidated statements of operations. Amortization expense for the CBR related intangibles is recorded in selling, general and administrative expenses in our condensed consolidated statements of operations. We expect amortization expense related to our finite-lived intangible assets to be as follows (in thousands):
 
Estimated
 
Amortization
Period
Expense
Remainder of Year Ending December 31, 2016
$
21,121

Year Ending December 31, 2017
90,826

Year Ending December 31, 2018
97,992

Year Ending December 31, 2019
68,993

Year Ending December 31, 2020
46,271

Thereafter
653,232

Total
$
978,435